Connected brands, including Connected Cannabis, AlienLabs and Smoken Promises branded products, to be distributed through the ENTOURAGE wholesale network and FLUENT retail storesNEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the commencement of operations at its new 68,000+ square-foot indoor cultivation facility in Buffalo, New York. This facility doubles FLUENT’s New York cultivation capacity and further strengthens its pre ...

Core Insights - MariMed Inc. has entered a strategic agreement with TILT Holdings to expand the distribution of its medical marijuana products to Pennsylvania [1][2] - Under a Management Services Agreement, MariMed will manage TILT's Standard Farms cultivation and processing facility in Pennsylvania starting September 1, 2025 [2][3] - MariMed will receive a management fee of 12.5% of Standard Farms' gross revenue for its management services [3] Company Overview - MariMed Inc. is recognized as a leading multi-state cannabis operator, known for its award-winning cannabis brands such as Betty's Eddies™, Bubby's Baked™, and Nature's Heritage™ [5] - The company aims to become a leading consumer packaged goods company in the medical marijuana sector through its "Expand the Brand" strategy [4] - TILT Holdings supports cannabis businesses with a diverse portfolio, including technology and cultivation services, and operates in multiple regions including North America and Europe [6] Market Context - Pennsylvania is identified as a strong medical marijuana market and is expected to transition into an adult-use market, presenting growth opportunities for MariMed [4] - The partnership with TILT is seen as a strategic move to leverage existing quality and trust established under the Standard Farms brand to enhance MariMed's market presence [4]

Core Insights - Delaware has announced the commencement of adult-use cannabis sales, marking a significant expansion of its cannabis program [1] - MariMed, through its Delaware business unit First State Compassion (FSC), is positioned to lead in this high-growth market due to its decade-long experience and investments [1][4] Company Developments - MariMed has made improvements to its two dispensaries in Wilmington and Lewes to accommodate increased customer traffic from both residents and the nearly 30 million annual tourists [2] - The company is scaling production at its cultivation and processing facilities in Wilmington and Milford to meet rising demand, including popular products like Betty's Eddies chews and its flower brands [3] Industry Context - The leadership of local officials, including State Representative Osienski and State Senator Paradee, has been acknowledged for their role in responsibly growing Delaware's cannabis industry [4] - MariMed is recognized as a leading multi-state cannabis operator with a portfolio of award-winning brands, emphasizing quality and innovation in the cannabis market [4]

Core Insights - TerrAscend Corp. has decided to exit the Michigan market as part of a strategic review, selling all Michigan assets including cultivation and processing facilities, retail dispensaries, and real estate [1][2][3] - The net proceeds from these divestitures will be utilized to pay down existing company debt, enhancing the financial profile of TerrAscend [1][2] - The exit from Michigan is expected to be substantially completed in the second half of 2025, with the Michigan operations reported as discontinued starting from Q2 2025 [1][2] Financial Impact - Following the Michigan exit, TerrAscend will operate 19 dispensaries and 4 cultivation and processing facilities across five states, which is anticipated to improve key financial metrics such as gross margin, adjusted EBITDA, and cash flow conversion [2][3] - The company expects a reduction of approximately 21% of its overall workforce, which consists of about 1,200 employees, primarily by the end of Q3 2025 [3] Strategic Focus - The strategic decision to exit Michigan is aimed at reallocating resources to core markets in the northeastern U.S., specifically New Jersey, Maryland, Pennsylvania, and Ohio, to unlock value for the company and its shareholders [3] - The company believes that concentrating efforts in these core markets will lead to stronger financial performance, improved margins, and operational efficiencies [3] Company Overview - TerrAscend is a leading cannabis company listed on the TSX, with operations across North America, including vertically integrated operations in several states and retail operations in Canada [4] - The company operates various dispensary brands and has a portfolio of synergistic businesses and brands, providing a wide selection of cannabis products for both medical and adult-use markets [4]

Core Insights - Verano Holdings Corp. has announced an exclusive partnership with Grow Sciences to introduce premium cannabis products to the Illinois market, starting June 21, 2025 [1][2][3] Group 1: Partnership Details - The partnership will initially offer Grow Sciences' products exclusively at Zen Leaf dispensaries in Illinois, with plans to expand to third-party dispensaries later [1][2] - Grow Sciences is recognized for its elite cannabis genetics and solventless extraction methods, and will introduce thirteen sought-after strains to Illinois, including Prickly Pear and Florida Jack [2][3] Group 2: Product Offerings - The product lineup includes flower eighths, 1-gram flower joints, live hash rosin cartridges, hash rosin extracts, and live rosin fruit chews, with various strains available for each product type [3][4] - Flower products will feature seven strains, while live hash rosin cartridges and extracts will include six strains each, showcasing the quality and variety of offerings [3][4] Group 3: Company Background - Verano Holdings is a leading multi-state cannabis operator with a mission to enhance the cannabis shopping experience across medical and adult-use markets [5] - The company operates in 13 U.S. states with over 1.1 million square feet of cultivation capacity, emphasizing quality and a diverse product portfolio [5]

Company Overview - Vireo Growth Inc. has successfully completed the acquisition of Deep Roots Holdings, a cannabis operator in Nevada [1][3] - Deep Roots operates a 54,000 square foot cultivation and manufacturing facility and has ten active retail dispensaries [2] Financial Details - The total consideration for the acquisition was $132.7 million, paid in 255.2 million Subordinate Voting Shares at a reference price of $0.52 per share [3] - The purchase price represents a multiple of 4.175x the 2024 "Closing EBITDA" of $30 million [3] - The transaction includes clawback provisions if the 2026 EBITDA falls below the Closing EBITDA as of December 31, 2026 [3] Strategic Positioning - Deep Roots benefits from strategically located stores in Southern Nevada, particularly near the Utah border, enhancing its market performance [2] - The company also holds equity and debt investments in a retail chain in California and a vertical operator in Ohio and Massachusetts [2] Company Background - Vireo was founded in 2014 as a pioneer in medical cannabis and focuses on empowering local market leaders and strategic resource allocation [4]